|
Volumn 28, Issue 4, 2002, Pages 277-
|
The influence of the pharmaceutical industry on the off-label use of its medicines (multiple letters)
a a
a
NONE
(Netherlands)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
THALIDOMIDE;
CLINICAL PROTOCOL;
CONSTIPATION;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG LABELING;
DRUG MARKETING;
DRUG MONITORING;
ERYTHRODERMA;
HUMAN;
LETTER;
MEDICAL ETHICS;
MORALITY;
NEUROPATHY;
PHARMACEUTICAL CARE;
REGISTRATION;
SEDATION;
TERATOGENICITY;
HEALTH CARE AND PUBLIC HEALTH;
DRUG INDUSTRY;
DRUG LABELING;
DUTY TO WARN;
ETHICS, MEDICAL;
GUIDELINE ADHERENCE;
HUMANS;
NETHERLANDS;
TERATOGENS;
THALIDOMIDE;
|
EID: 0036057779
PISSN: 03066800
EISSN: None
Source Type: Journal
DOI: 10.1136/jme.28.4.277 Document Type: Letter |
Times cited : (1)
|
References (0)
|